Close Menu
FintechFetch
    FintechFetch
    • Home
    • Fintech
    • Financial Technology
    • Credit Cards
    • Finance
    • Stock Market
    • More
      • Business Startups
      • Blockchain
      • Bitcoin News
      • Cryptocurrency
    FintechFetch
    Home»Business Startups»How One Founder Is Rethinking Supplements With David Beckham
    Business Startups

    How One Founder Is Rethinking Supplements With David Beckham

    FintechFetchBy FintechFetchJuly 2, 2025No Comments5 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Opinions expressed by Entrepreneur contributors are their own.

    When Danny Yeung sat down for dinner with soccer legend David Beckham, there was no agenda. No pitch deck. Just two guys talking health.

    They met through a mutual friend in Hong Kong. Yeung, the CEO of Prenetics, a health tech company specializing in genomics and diagnostics, wanted to create a wellness brand rooted in science. Beckham wanted a product he could take every day without juggling a shelf full of pills.

    That conversation led to the creation of IM8, a supplement powder designed to support energy, gut health, immunity, and focus. In five months, it has shipped more than 3 million servings to customers in 31 countries. The growth has been sizeable. In its first full quarter of sales, IM8 generated $5.7 million in revenue, helping Prenetics raise its full-year forecast to between $80 and $100 million.

    Beckham’s endorsement helped, of course. But Yeung says the goal wasn’t just to put a famous face on the box. It was to create something the founder and the athlete would both want to use. Beckham takes the product daily. His kids take it. His parents do, too.

    “If this product didn’t work, David wouldn’t use it—and neither would I,” Yeung says. “We built it for ourselves first. Everything else came after.”

    Here’s what Yeung learned in building the company.

    Lesson 1: Start with science

    Yeung says the vast majority of supplement companies work backward—designing the brand first and then sourcing ingredients to fit a specific price point. “They lead with a logo and build the formula later,” he says. “That’s not how it should work.”

    IM8 reversed the process. Before a single package was designed, the company spent over a year developing the formula with scientists and doctors, many of whom had never partnered with a supplement brand before.

    “We approached it like a biotech company,” Yeung says. “We had real clinical trials, real data. No fluff.”

    Related: The Supplement Business Has a Trust Problem. This Tech Startup Wants to Fix That.

    Lesson 2: Transparency isn’t optional

    With more than 200,000 supplements on the market and little federal oversight, many consumers are understandably skeptical. “You can sell dust and call it protein. That’s legal. That’s the reality,” says Yeung.

    IM8 tries to counter that with full transparency. The formula includes over 90 ingredients, including CoQ10, prebiotics, probiotics, and postbiotics. It’s NSF Certified for Sport. Lab test results are published online. And the company publicly names its manufacturing partner.

    Lesson 3: Keep it simple

    Beckham wanted fewer pills in his daily routine. The idea behind IM8’s Daily Ultimate Essentials was to simplify supplementation: one scoop, once a day, covering multiple health needs.

    The brand has plans to expand, but only with a few highly vetted products per year. Yeung emphasizes quality over speed.

    “We’re not a company that wants to launch 50 different products. We want to focus on doing a few things very well. If we don’t think something is best in class, we won’t do it.”

    Yeung’s taking that same mindset to the business side. Prenetics is in active discussions with crypto industry veterans to integrate Bitcoin into its treasury strategy.

    Related: Inside The New Era of Longevity Supplements

    Lesson 4: A celebrity partner can’t fix a bad product

    Yeung says too many founders look for celebrity partners to grab attention, not to build staying power. “I didn’t want to be just another celebrity brand. We’ve seen too many of those,” he says.

    That’s why he didn’t pitch Beckham on a business. They met over dinner. Talked science. Swapped health routines. “It wasn’t a transaction,” Yeung says. “It was two people figuring out if they believed in the same thing.”

    Yeung believes Beckham didn’t just join because of a business opportunity, but because he believed in the science.

    He has been involved in the process, reviewing product iterations, offering feedback on packaging, and flagging early customer reactions.

    Lesson 5: Trust has to be earned

    You can put a famous face on your brand, but if it doesn’t work, you’re not going to last. “People know when something’s real,” he says. “You can’t fake that.”

    Yeung calls IM8 a “trust product.” Customers are putting it in their bodies every day, and that responsibility shapes how the business operates.

    The brand’s 12-week clinical study showed that 95% of participants reported feeling more energized. Customer retention is strong. And feedback, Yeung says, has been more meaningful than any marketing metric.

    “If people are putting this in their bodies every day, you better get it right.”

    Related: Trust Is a Business Metric Now. Here’s How Leaders Can Earn It.

    When Danny Yeung sat down for dinner with soccer legend David Beckham, there was no agenda. No pitch deck. Just two guys talking health.

    They met through a mutual friend in Hong Kong. Yeung, the CEO of Prenetics, a health tech company specializing in genomics and diagnostics, wanted to create a wellness brand rooted in science. Beckham wanted a product he could take every day without juggling a shelf full of pills.

    That conversation led to the creation of IM8, a supplement powder designed to support energy, gut health, immunity, and focus. In five months, it has shipped more than 3 million servings to customers in 31 countries. The growth has been sizeable. In its first full quarter of sales, IM8 generated $5.7 million in revenue, helping Prenetics raise its full-year forecast to between $80 and $100 million.

    The rest of this article is locked.

    Join Entrepreneur+ today for access.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleBitcoin Casascius Bar Bought for $500 Now Worth $10 Million
    Next Article QuickBooks Forum Spotlights AI’s Growing Role in the Accounting Sector
    FintechFetch
    • Website

    Related Posts

    Business Startups

    Tell Your Story and Share Your Strategies with the $49 Youbooks Tool

    August 3, 2025
    Business Startups

    Target Retirement Ages and Average Savings: Gen Z to Boomer

    August 3, 2025
    Business Startups

    10 Things That Separate Successful Founders From the Unsuccessful

    August 3, 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Why Entrepreneurship Is the Cure to an Unstable Economy

    March 23, 2025

    10x Banking and Constantinople Join Forces to Tackle Digital Transformation Hurdles

    June 27, 2025

    Syfe Moves Forward with A$65 Million Selfwealth Acquisition Pending Court Nod

    April 23, 2025

    The One Mistake Is Putting Your Brand Reputation at Risk — and Most Startups Still Make It

    April 18, 2025

    Solana, DOGE, And ADA Shine While Bitcoin Stalls

    March 25, 2025
    Categories
    • Bitcoin News
    • Blockchain
    • Business Startups
    • Credit Cards
    • Cryptocurrency
    • Finance
    • Financial Technology
    • Fintech
    • Stock Market
    Most Popular

    How to Turn Complaints, Comments and Compliments Into Business Wins

    June 12, 2025

    2023’s Best Credit Cards for Dining Out at Restaurants

    February 5, 2025

    Tether Reportedly Holding $8B in Gold in Secret Swiss Vault

    July 9, 2025
    Our Picks

    Tell Your Story and Share Your Strategies with the $49 Youbooks Tool

    August 3, 2025

    Is This the Time to Sell XRP? Analysts Eye a Lower Re-entry Point

    August 3, 2025

    Worried about a market crash in 2025? These could be among the best stocks to consider buying

    August 3, 2025
    Categories
    • Bitcoin News
    • Blockchain
    • Business Startups
    • Credit Cards
    • Cryptocurrency
    • Finance
    • Financial Technology
    • Fintech
    • Stock Market
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us
    Copyright © 2024 Fintechfetch.comAll Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.